MétaCan
Menu
Back to cohort
Record W4404048194 · doi:10.3389/fonc.2024.1437360

Multidisciplinary Canadian consensus on the multimodal management of high-risk and radioactive iodine-refractory thyroid carcinoma

2024· review· en· W4404048194 on OpenAlexafffundabout
Shereen Ezzat, Jesse D. Pasternak, Murali Rajaraman, Omar Abdel‐Rahman, Andrée Boucher, Nicole G. Chau, Shirley Chen, Sabrina Gill, Martin Hyrcza, Nathan Lamond, Marie-Hélène Massicotte, Eric Winquist, Özgür Mete

Bibliographic record

VenueFrontiers in Oncology · 2024
Typereview
Languageen
FieldMedicine
TopicThyroid Cancer Diagnosis and Treatment
Canadian institutionsLondon Health Sciences CentreUniversity of TorontoUniversité de SherbrookeCentre Hospitalier Universitaire de SherbrookeToronto Western HospitalNova Scotia Cancer CentreUniversity of British ColumbiaPrincess Margaret Cancer CentreUniversity of CalgaryCentre Hospitalier de l’Université de MontréalUniversity of AlbertaUniversity Health NetworkDalhousie UniversityBC Cancer Agency
FundersBayer CanadaEMD SeronoGenentechBeiGeneIpsenEisaiSanofiAmgenPfizerEli Lilly and CompanyBristol-Myers SquibbGlaxoSmithKline
KeywordsMedicineThyroid carcinomaRadiation therapyThyroid cancerMultidisciplinary approachMalignancyThyroidReimbursementRadioactive iodineOncologyRefractory (planetary science)DiseaseIntensive care medicineInternal medicineHealth care

Abstract

fetched live from OpenAlex

Most follicular cell-derived differentiated thyroid carcinomas are regarded as low-risk neoplasms prompting conservative therapeutic management. Here, we provide consensus recommendations reached by a multidisciplinary group of endocrinologists, medical oncologists, pathologists, radiation oncology specialists, a surgeon and a medication reimbursement specialist, addressing more challenging forms of this malignancy, focused on radioactive iodine (RAI)-resistant or -refractory differentiated thyroid carcinoma (RAIRTC). In this document we highlight clinical, radiographic, and molecular features providing the basis for these management plans. We distinguish differentiated thyroid cancers associated with more aggressive behavior from thyroid cancers manifesting as poorly differentiated and/or anaplastic carcinomas. Treatment algorithms based on risk-benefit assessments of different multimodal therapy approaches are also discussed. Given the scarcity of data supporting management of this rare yet aggressive disease entity, these consensus recommendations provide much needed guidance for multidisciplinary teams to optimally manage RAIRTC.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.006
metaresearch head score (Gemma)0.008
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Not applicable · Consensus signal: none
GenreCandidate signal: Review · Consensus signal: Review
Teacher disagreement score0.965
Threshold uncertainty score0.070

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0060.008
Meta-epidemiology (narrow)0.0010.000
Meta-epidemiology (broad)0.0010.001
Bibliometrics0.0030.003
Science and technology studies0.0010.001
Scholarly communication0.0020.001
Open science0.0020.001
Research integrity0.0020.003
Insufficient payload (model declined to judge)0.0030.001

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.026
GPT teacher head0.321
Teacher spread0.295 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designNot applicable
Domainnot available
GenreReview

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations5
Published2024
Admission routes3
Has abstractyes

Explore more

Same venueFrontiers in OncologySame topicThyroid Cancer Diagnosis and TreatmentFrench-language works237,207